Jeffrey R. Moore - Jul 11, 2023 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Director
Signature
/s/ Marella Thorell, Attorney-in-Fact for Jeffrey R. Moore
Stock symbol
EVLO
Transactions as of
Jul 11, 2023
Transactions value $
$0
Form type
4
Date filed
7/12/2023, 04:05 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +2K $0.00 2K Jul 11, 2023 Common Stock 2K $3.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years.

Remarks:

On June 29, 2023, the Issuer effected a 1-for-20 reverse stock split. The share counts herein have been adjusted to reflect the reverse stock split.